Lv61
2775 积分 2021-11-11 加入
天下本无事，庸人自扰之~
TP53 co-mutations increase risk of recurrence in EGFR-mutated stage I lung adenocarcinoma
5小时前
已完结
EGFR status assessment using reflex testing targeted next-generation sequencing for resected non-squamous non-small cell lung cancer
5小时前
已完结
Clinical, Pathologic, and Molecular Prognostic Factors in Patients with Early-Stage EGFR-Mutant NSCLC
5小时前
已完结
PD-L1 Expression and Comprehensive Molecular Profiling Predict Survival in Nonsmall Cell Lung Cancer: A Real-World Study of a Large Chinese Cohort
6小时前
已完结
Effectiveness of alectinib and osimertinib in a brain metastasized lung adenocarcinoma patient with concurrent EGFR mutations and DCTN1‐ALK fusion
7天前
已完结
Clinical characteristics and sequence complexity of anaplastic lymphoma kinase gene fusions in Chinese lung cancer patients
7天前
已完结
Adénocarcinome bronchique avec mutation de l’ EGFR et réarrangement ALK concomitants
7天前
已完结
Variations in Molecular Profile in NSCLC Can Be Analyzed Using Cytological Samples
7天前
已完结
Coexistence of EGFR mutation and ALK translocation in NSCLC: Literature review and case report of response to gefitinib
7天前
已完结
EML4-ALK Rearrangement and Its Clinical Significance in Chinese Patients with Advanced Non-Small Cell Lung Cancer
7天前
已完结
皖公网安备34019202002308
